{
    "fund_name": "iShares AEX UCITS ETF",
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The iShares AEX UCITS ETF is classified as non-complex under MiFID II for the following reasons:1. **Physical Replication**: The fund uses physical replication to track the AEX Index, directly investing in the 25 largest Dutch companies listed on NYSE Euronext Amsterdam. This is explicitly stated in the KIID ('The Fund intends to replicate the Index by holding the equity securities, which make up the Index, in similar proportions to it') and confirmed in the PRIIPs KID ('Product Structure: Physical').2. **No Derivative Usage for Investment Objective**: While the KIID mentions that the fund 'may use financial derivative instruments (FDIs) to help achieve the Funds investment objective,' this is a standard disclosure and does not indicate actual usage. The PRIIPs KID explicitly states 'Product Structure: Physical,' and the fact sheet confirms the fund holds the underlying equities directly. There is no mention of swaps, synthetic replication, or derivative-based strategies in any of the documents.3. **No Leverage or Inverse Exposure**: The fund does not employ leverage, inverse strategies, or any form of amplified returns. The risk profile is straightforward, with the fund's performance closely tracking the AEX Index.4. **Transparent and Liquid Underlying Assets**: The fund invests in large-cap Dutch equities, which are highly liquid and transparent. The top 10 holdings (e.g., Unilever, Shell, ASML) are well-known, publicly traded companies.5. **No Complex Structured Features**: There are no capital protection mechanisms, barrier options, or other structured features that would increase complexity. The fund's objective is simple: to replicate the AEX Index.6. **Risk Profile**: The fund is rated as '6' on the risk scale, which is typical for equity funds and does not indicate complexity. The risks are clearly disclosed and relate to equity market volatility, concentration risk, and counterparty risk (though the latter is minimal given the physical replication approach).7. **No Counterparty Risk from Derivatives**: While the KIID mentions counterparty risk, this is a standard disclosure for any fund that may use derivatives (even if not actively). The physical replication method means there is no material counterparty risk from derivatives.8. **UCITS Compliance**: The fund is UCITS-compliant, which inherently limits the use of complex strategies and derivatives. UCITS funds are subject to strict regulations that restrict the use of derivatives to simple hedging or efficient portfolio management, not for speculative purposes.**Counterargument and Override**: One might argue that the mention of derivative usage in the KIID could imply complexity. However, this is a standard legal disclosure and does not reflect actual practice. The PRIIPs KID and fact sheet confirm the physical replication method, and there is no evidence of derivative usage beyond what is permitted for efficient portfolio management (e.g., hedging or securities lending). The absence of any mention of swaps, synthetic replication, or derivative-based strategies in the fact sheet further supports the non-complex classification.**Confidence Score**: 95% - The evidence overwhelmingly supports a non-complex classification, with the only minor uncertainty stemming from the generic derivative disclosure in the KIID. However, this is standard for UCITS funds and does not override the physical replication method confirmed in the PRIIPs KID and fact sheet.",
    "confidence": 95
}